12 employees
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
2018
$40M
from 3 investors over 3 rounds
CERo Therapeutics, Inc. raised $40M on March 18, 2020
Investors: Sequoia Capital China, ARCH Venture Partners and Lyell Immunopharma